Vittorio Rosti Selected Research

Vittorio Rosti Research Topics

Disease

28	Primary Myelofibrosis (Myelosclerosis) 09/2021 - 08/2005
25	Neoplasms (Cancer) 10/2021 - 03/2009
7	Polycythemia Vera 01/2021 - 03/2009
7	Splenomegaly 01/2019 - 12/2007
5	Anemia 02/2021 - 02/2010
5	Essential Thrombocythemia 01/2020 - 03/2009
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 03/2005
4	Myocardial Infarction 01/2021 - 08/2007
4	Thrombosis (Thrombus) 02/2017 - 03/2009
3	Fibrosis (Cirrhosis) 11/2019 - 01/2012
3	Myeloproliferative Disorders (Myeloproliferative Disorder) 10/2019 - 08/2005
3	Inflammation (Inflammations) 12/2018 - 02/2010
3	Disease Progression 01/2017 - 08/2014
3	Infarction (Infarctions) 05/2015 - 02/2011
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 01/2013
2	Leukemia 01/2019 - 03/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2018 - 02/2014
2	Breast Neoplasms (Breast Cancer) 11/2017 - 01/2014
1	Thrombocytopenia (Thrombopenia) 02/2021
1	Cardiotoxicity 01/2021
1	Adenocarcinoma 03/2020
1	Hypoxia (Hypoxemia) 11/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2019
1	Wilms Tumor (Wilm's Tumor) 01/2019
1	Hyperplasia 01/2019
1	Kidney Neoplasms (Kidney Cancer) 12/2018
1	Genomic Instability 12/2018
1	Pathologic Complete Response 01/2018
1	Hemangioma (Angioma) 02/2016
1	Liver Neoplasms (Liver Cancer) 01/2016
1	Wounds and Injuries (Trauma) 01/2016
1	Glioblastoma (Glioblastoma Multiforme) 01/2014
1	ST Elevation Myocardial Infarction 10/2013

Drug/Important Bio-Agent (IBA)

8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 09/2007
8	Biological ProductsIBA 05/2021 - 09/2007
6	Hemoglobins (Hemoglobin)IBA 01/2018 - 12/2007
5	ruxolitinibIBA 03/2020 - 03/2009
4	Janus Kinase 2IBA 01/2021 - 03/2009
4	Proteins (Proteins, Gene)FDA Link 11/2019 - 03/2005
4	InterferonsIBA 10/2019 - 09/2007
4	CytokinesIBA 12/2018 - 09/2007
3	CalreticulinIBA 01/2020 - 08/2014
3	erucylphosphocholineIBA 09/2015 - 01/2012
3	Erythropoietin FDA Link 02/2011 - 08/2007
2	Chemokine ReceptorsIBA 01/2021 - 05/2007
2	Conditioned Culture MediaIBA 01/2021 - 05/2015
2	CholesterolIBA 11/2019 - 01/2012
2	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2019 - 01/2016
2	Fibronectins (Fibronectin)IBA 01/2019 - 01/2016
2	Thrombopoietin (c-mpl Ligand)IBA 01/2019 - 09/2007
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2017 - 02/2014
2	C-Reactive ProteinIBA 01/2017 - 01/2016
2	IronIBA 06/2013 - 02/2010
2	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2013 - 01/2011
2	pomalidomideIBA 03/2012 - 07/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2010 - 09/2007
1	NucleotidesIBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 09/2021
1	ChemokinesIBA 05/2021
1	OMS 2017IBA 02/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2021
1	givinostatIBA 01/2021
1	RNA Splicing FactorsIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	CalciumIBA 01/2020
1	Extracellular Matrix ProteinsIBA 11/2019
1	peginterferon alfa-2a (Pegasys)FDA Link 10/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	romiplostim FDA Link 01/2019
1	human extra domain A fibronectinIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019
1	AntigensIBA 01/2019
1	Angiogenesis InhibitorsIBA 12/2018
1	MTOR InhibitorsIBA 12/2018
1	CollagenIBA 10/2017
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 10/2017
1	TrabectedinIBA 01/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2016
1	Janus Kinase 1IBA 01/2016
1	Angiopoietin-2IBA 01/2016
1	TIE-2 Receptor (Receptor, TIE 2)IBA 01/2016
1	Nicotinamide PhosphoribosyltransferaseIBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	MicroRNAs (MicroRNA)IBA 09/2014
1	Messenger RNA (mRNA)IBA 09/2014
1	Transient Receptor Potential ChannelsIBA 02/2014
1	Phosphotransferases (Kinase)IBA 10/2013
1	CreatinineIBA 10/2013
1	Ferritins (Ferritin)IBA 06/2013

Therapy/Procedure

12	Therapeutics 10/2019 - 12/2007
4	Drug Therapy (Chemotherapy) 01/2018 - 12/2009
4	Splenectomy 01/2016 - 12/2007
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 09/2010
2	Transplantation 01/2019 - 01/2018
2	Percutaneous Coronary Intervention 10/2013 - 02/2011
1	Stem Cell Transplantation 01/2019
1	Molecular Targeted Therapy 01/2015
1	Aftercare (After-Treatment) 01/2014
1	Ischemic Postconditioning 10/2013